• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测丙型肝炎病毒抗体阳性患者现患丙型肝炎病毒感染的因素。

Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody.

机构信息

Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2013 Dec;19(4):376-81. doi: 10.3350/cmh.2013.19.4.376. Epub 2013 Dec 28.

DOI:10.3350/cmh.2013.19.4.376
PMID:24459642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3894437/
Abstract

BACKGROUND/AIMS: To identify the predicting factors of present hepatitis C virus (HCV) infection among patients with positivity for antibodies to HCV (anti-HCV).

METHODS

We analyzed patients who showed positive enzyme immunoassay (EIA) results and performed an HCV RNA test as a confirmatory test at Kyung Hee University Hospital at Gangdong from June 2006 to July 2012. The features distinguishing the groups with positive and negative HCV RNA results were reviewed.

RESULTS

In total, 490 patients were included. The results of the HCV RNA test were positive and negative in 228 and 262 patients, respectively. The index value of anti-HCV, mean age, platelet counts, total bilirubin, prothrombin time international normalized ratio, albumin and alanine transaminase (ALT) levels differed significantly between the two groups. On multivariable analysis, an index value of anti-HCV >10 [odds ratio (OR)=397.27, P<0.001), ALT >40 IU/L (OR=3.64, P=0.001), and albumin <3.8 g/dL (OR=2.66, P=0.014) were related to present HCV infection.

CONCLUSIONS

Although EIA is not a quantitative test, considering the anti-HCV titer with ALT and albumin levels may be helpful in predicting present of HCV infection.

摘要

背景/目的:确定抗 HCV 抗体阳性患者中当前 HCV 感染的预测因素。

方法

我们分析了 2006 年 6 月至 2012 年 7 月在庆熙大学东光医院进行酶免疫分析(EIA)结果阳性并进行 HCV RNA 检测作为确认试验的患者。回顾了 HCV RNA 结果阳性和阴性组之间的特征差异。

结果

共纳入 490 例患者。HCV RNA 检测结果阳性和阴性的患者分别为 228 例和 262 例。两组抗 HCV 指数值、平均年龄、血小板计数、总胆红素、凝血酶原时间国际标准化比值、白蛋白和丙氨酸转氨酶(ALT)水平差异有统计学意义。多变量分析显示,抗 HCV 指数值>10[比值比(OR)=397.27,P<0.001)、ALT>40IU/L(OR=3.64,P=0.001)和白蛋白<3.8g/dL(OR=2.66,P=0.014)与当前 HCV 感染相关。

结论

尽管 EIA 不是定量检测,但考虑到抗 HCV 滴度与 ALT 和白蛋白水平相结合,可能有助于预测当前 HCV 感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866d/3894437/2cb819015660/cmh-19-376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866d/3894437/b4a986d0ac71/cmh-19-376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866d/3894437/2cb819015660/cmh-19-376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866d/3894437/b4a986d0ac71/cmh-19-376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866d/3894437/2cb819015660/cmh-19-376-g002.jpg

相似文献

1
Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody.预测丙型肝炎病毒抗体阳性患者现患丙型肝炎病毒感染的因素。
Clin Mol Hepatol. 2013 Dec;19(4):376-81. doi: 10.3350/cmh.2013.19.4.376. Epub 2013 Dec 28.
2
Diagnostic discordance for hepatitis C virus infection in hemodialysis patients.血液透析患者丙型肝炎病毒感染的诊断不一致性
Am J Kidney Dis. 2005 Aug;46(2):290-300. doi: 10.1053/j.ajkd.2005.05.006.
3
[Evaluation of the patients with low levels of anti-HCV positivity].[抗丙型肝炎病毒(HCV)阳性水平较低患者的评估]
Mikrobiyol Bul. 2009 Jan;43(1):133-9.
4
Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.血液透析患者中抗丙型肝炎病毒阳性者的丙型肝炎病毒RNA。与转氨酶水平的关系。
ASAIO J. 1994 Jul-Sep;40(3):M450-3. doi: 10.1097/00002480-199407000-00040.
5
Screening of hepatitis C virus genotypes in urticaria patients in Saudi Arabia.沙特阿拉伯荨麻疹患者丙型肝炎病毒基因型的筛查。
Genet Test Mol Biomarkers. 2012 Aug;16(8):964-7. doi: 10.1089/gtmb.2012.0014. Epub 2012 Jul 12.
6
Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.使用逆转录巢式聚合酶链反应诊断巴西献血者中的丙型肝炎病毒:与酶免疫测定和重组蛋白免疫印迹法的比较
Rev Inst Med Trop Sao Paulo. 2000 Sep-Oct;42(5):263-7. doi: 10.1590/s0036-46652000000500005.
7
Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.合并感染人类免疫缺陷病毒1型对丙型肝炎病毒诊断和评估的影响。
J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):340-4. doi: 10.1097/00126334-200104010-00008.
8
[Investigation of Anti-HCV S/CO Value in Detecting Viremia in Patients with Hepatitis C Virus Infection].[丙型肝炎病毒感染患者抗-HCV S/CO值检测病毒血症的研究]
Mikrobiyol Bul. 2020 Jan;54(1):110-119. doi: 10.5578/mb.68833.
9
Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.丙型肝炎病毒抗体酶免疫测定特异性和非特异性结果的年龄、性别及转氨酶依赖性以及献血者随访情况
Infusionsther Transfusionsmed. 1995 Aug;22(4):208-19. doi: 10.1159/000223127.
10
[Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].[丙氨酸转氨酶筛查在献血者中对降低血液疗法传播乙型和丙型肝炎风险的意义]
Vnitr Lek. 2016 Jan;62(1):9-16.

引用本文的文献

1
The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection.丙型肝炎病毒抗体水平对慢性丙型肝炎病毒感染的诊断意义。
Korean J Intern Med. 2023 May;38(3):362-371. doi: 10.3904/kjim.2022.350. Epub 2023 Apr 11.
2
A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective.韩国基于社会视角的丙型肝炎病毒感染普遍筛查的成本效益研究。
Clin Mol Hepatol. 2022 Jan;28(1):91-104. doi: 10.3350/cmh.2021.0236. Epub 2021 Nov 5.
3
Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity.

本文引用的文献

1
Different signal-to-cut-off ratios from three automated anti-hepatitis C virus chemiluminescence immunoassays in relation to results of recombinant immunoblot assays and nucleic acid testing.三种自动化抗丙型肝炎病毒化学发光免疫分析方法的不同信号与截断值之比与重组免疫印迹分析及核酸检测结果的关系。
Blood Transfus. 2013 Jul;11(3):471-3. doi: 10.2450/2012.0085-12. Epub 2012 Nov 20.
2
The value of screening signal-to-cutoff ratios for hepatitis C virus antibody confirmation.筛查丙型肝炎病毒抗体确认的信号-截止比值的价值。
Transfusion. 2013 Jul;53(7):1497-500. doi: 10.1111/j.1537-2995.2012.03955.x. Epub 2012 Nov 26.
3
初步证据表明,HCV 感染患者的血浆 TNFα 水平升高与较小的皮质下白质体积有关,而与 HIV 或 AUD 合并症无关。
Int J Mol Sci. 2021 May 7;22(9):4953. doi: 10.3390/ijms22094953.
4
Peripheral TNFα elevations in abstinent alcoholics are associated with hepatitis C infection.戒酒的酗酒者外周血肿瘤坏死因子α水平升高与丙型肝炎感染有关。
PLoS One. 2018 Feb 6;13(2):e0191586. doi: 10.1371/journal.pone.0191586. eCollection 2018.
5
Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.估算韩国丙型肝炎一次性筛查和治疗的成本效益
PLoS One. 2017 Jan 6;12(1):e0167770. doi: 10.1371/journal.pone.0167770. eCollection 2017.
Role of signal-to-cutoff ratios in hepatitis C virus antibody detection.
信号截断比在丙型肝炎病毒抗体检测中的作用。
Clin Vaccine Immunol. 2012 Aug;19(8):1329-31. doi: 10.1128/CVI.00175-12. Epub 2012 Jun 13.
4
EASL Clinical Practice Guidelines: management of hepatitis C virus infection.欧洲肝脏研究学会临床实践指南:丙型肝炎病毒感染的管理
J Hepatol. 2011 Aug;55(2):245-64. doi: 10.1016/j.jhep.2011.02.023. Epub 2011 Mar 1.
5
Insulin resistance and hepatitis C: an evolving story.胰岛素抵抗与丙型肝炎:一个不断发展的故事。
Gut. 2011 Aug;60(8):1139-51. doi: 10.1136/gut.2010.228262. Epub 2011 Jan 19.
6
Diagnosis, management, and treatment of hepatitis C: an update.丙型肝炎的诊断、管理与治疗:最新进展
Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759.
7
Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.两种基于实时荧光定量PCR的丙型肝炎病毒(HCV)检测方法(实时HCV检测法和Cobas AmpliPrep/Cobas TaqMan检测法)与一种信号放大检测法(Versant HCV RNA 3.0)在RNA检测和定量方面的差异。
J Clin Microbiol. 2008 Dec;46(12):3880-91. doi: 10.1128/JCM.00755-08. Epub 2008 Sep 17.
8
Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.新型丙型肝炎检测方法在拜耳ADVIA Centaur免疫分析系统上的性能表现。
Clin Lab. 2004;50(1-2):75-82.
9
Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.丙型肝炎病毒抗体实验室检测及结果报告指南。疾病控制与预防中心。
MMWR Recomm Rep. 2003 Feb 7;52(RR-3):1-13, 15; quiz CE1-4.
10
Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests.AMPLICOR和COBAS AMPLICOR丙型肝炎病毒检测的前瞻性多中心临床评估。
J Clin Microbiol. 2001 Nov;39(11):4005-12. doi: 10.1128/JCM.39.11.4005-4012.2001.